| Literature DB >> 25380457 |
Leonardo Zanchetti Meneghini1, Gabriel Rübensam2, Vinicius Claudino Bica3, Amanda Ceccon4, Fabiano Barreto5, Marco Flores Ferrão6, Ana Maria Bergold7.
Abstract
A simple and inexpensive method based on solvent extraction followed by low temperature clean-up was applied for determination of seven pyrethroids residues in bovine raw milk using gas chromatography coupled to tandem mass spectrometry (GC-MS/MS) and gas chromatography with electron-capture detector (GC-ECD). Sample extraction procedure was established through the evaluation of seven different extraction protocols, evaluated in terms of analyte recovery and cleanup efficiency. Sample preparation optimization was based on Doehlert design using fifteen runs with three different variables. Response surface methodologies and polynomial analysis were used to define the best extraction conditions. Method validation was carried out based on SANCO guide parameters and assessed by multivariate analysis. Method performance was considered satisfactory since mean recoveries were between 87% and 101% for three distinct concentrations. Accuracy and precision were lower than ±20%, and led to no significant differences (p < 0.05) between results obtained by GC-ECD and GC-MS/MS techniques. The method has been applied to routine analysis for determination of pyrethroid residues in bovine raw milk in the Brazilian National Residue Control Plan since 2013, in which a total of 50 samples were analyzed.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25380457 PMCID: PMC4245621 DOI: 10.3390/ijerph111111421
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1General structure of the pyrethroids included in the study.
Substituted radicals represented in the Figure 1 for each pyrethroid.
| Pyrethroid | MW a | R1 b | R2 b | R3 b | R4 b |
|---|---|---|---|---|---|
| Gamma-cyhalothrin | 449.9 | Cl | CF3 | CN | H |
| Lambda-cyhalothrin | 449.9 | Cl | CF3 | CN | H |
| cyfluthrin | 391.3 | Cl | Cl | H | H |
| cypermethrin | 434.4 | Cl | Cl | CN | F |
| permethrin | 391.3 | Cl | Cl | CN | H |
| deltamethrin | 434.4 | Br | Br | CN | H |
| fenvalerate | 416.3 | H | Cl | CN | H |
Notes: a molecular weight; b susbtituted radical represented in the Figure 1.
Figure 2Summary of the procedures evaluated for sample preparation.
Doehlert matrix for the variables used in sample preparation optimization.
| Experiment a | Coded Values b | Planned Values c | ||||
|---|---|---|---|---|---|---|
| Agitation Time (min) | ACN (mL) | Homogenization Time (s) | ||||
| 1 | 1 | 0 | 0 | 30 | 10.5 | 10.0 |
| 2 | 0.5 | 0.866 | 0 | 25 | 13.5 | 10.0 |
| 3 | 0.5 | 0.289 | 0.817 | 25 | 11.5 | 14.4 |
| 4 | −1 | 0 | 0 | 10 | 10.5 | 10.0 |
| 5 | −0.5 | −0.866 | 0 | 15 | 7.5 | 10.0 |
| 6 | −0.5 | −0.289 | −0.817 | 15 | 9.5 | 5.6 |
| 7 | 0.5 | −0.866 | 0 | 25 | 7.5 | 10.0 |
| 8 | 0.5 | −0.289 | −0.817 | 25 | 9.5 | 5.6 |
| 9 | −0,5 | 0.866 | 0 | 15 | 13.5 | 10.0 |
| 10 | 0 | 0.577 | −0.817 | 20 | 12.5 | 5.6 |
| 11 | −0.5 | 0.289 | 0.817 | 15 | 11.5 | 14.4 |
| 12 | 0 | −0.577 | 0.817 | 20 | 8.5 | 14.4 |
| 13 | 0 | 0 | 0 | 20 | 10.5 | 10.0 |
| 14 | 0 | 0 | 0 | 20 | 10.5 | 10.0 |
| 15 | 0 | 0 | 0 | 20 | 10.5 | 10.0 |
Notes: a Experiments performed in random order with number 13 until 15 used as central points of design; b Codes t, V, H correspond to Agitation time, ACN, Homogenization time, respectively; c ACN is the solvent employed as starting solvent in the procedure.
Recoveries obtained in screening evaluation of sample preparation method and in the optimized condition using Doehlert design study.
| Sample Preparation Initial Screening | ||||
|---|---|---|---|---|
| Procedure a | RE (%) b | CV (%) c | CoE (mg) d | CE (abs) e |
| P01 (MSPD) | 50–60 | 35 | 8.0 | 0.455 |
| P02 (HEX) | 30–50 | 30 | 17.5 | 0.460 |
| P03 (ACO) | 50–60 | 25 | 15.4 | 0.508 |
| P04 (EAC) | 50–60 | 23 | 22.5 | 0.780 |
| P05 (ACN) | 50–60 | 22 | 5.1 | 0.320 |
| P06 (ACN) | 80–90 | 20 | 7.2 | 0.340 |
| P07 (ACN) | 80–90 | 20 | 7.4 | 0.335 |
| 20.0 | 10.5 | 10.0 | ||
| (l-CYH) | ||||
| (PER) | ||||
| (g-CYH) | ||||
| (CYF) | ||||
| (CYP) | ||||
| (DEL) | ||||
| (FEV) | ||||
Notes: a Procedures coded in the screening, see Section 2.3 and Figure 2; b Range obtained for the seven PYR analyzed; c Coefficient of variation obtained for each procedure; d co-extractive material (CoE) evaluated by gravimetric measurement before reconstitution and injection; e Trinder method (505 nm, Analisa® assay kit) used to co-extractive measurement (n = 6); f Final parameters optimized by P07; g Quadratic polynomials containing significant coefficients to recovery (R%) for each PYR.
Figure 3Response surfaces (RSMs) obtained using Doehlert design for recovery (%R) as response; volume of solvent (V) and time of agitation (t) were the significant factors obtained from modeling.
Comparison data between chromatographic systems.
| Analyte | RT a | RE (%) b | |||
|---|---|---|---|---|---|
| MS/MS | ECD | MS/MS | ECD | ||
| CYH-g | 20.74 | 17.43 | 97.5 | 86.8 | −1.05 |
| CYH-l | 21.10 | 17.77 | 96.9 | 85.2 | 1.20 |
| PER | 22.63 | 18.91 | 97.7 | 88.9 | 0.89 |
| CYF | 23.96 | 20.22 | 93.28 | 91.49 | 0.56 |
| CYP | 24.53 | 20.56 | 96.67 | 85.15 | 1.60 |
| DEL | 25.83 | 22.14 | 99.95 | 92.85 | 0.80 |
| FEV | 27.23 | 23.14 | 95.50 | 88.50 | 0.76 |
Notes: a; b Coefficient of regression obtained from matrix-matched calibration curves; c Limit of determination obtained from matrix-matched calibration curves; d Limit of quantification obtained from matrix-matched calibration curves; e Validation.
Summary of validation parameters.
| 0.5 VL e | 1.0 VL | 1.5 VL | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RE (%) f | CV (%) g | CV (%) h | RE (%) | CV (%) | CV (%) | RE (%) | CV (%) | CV (%) | ||||
| CYH-g(25)(2) | 0.99 | 0.3 | 0.9 | 95.4 | 12.3 | 10.4 | 92.1 | 8.5 | 13.7 | 96.5 | 8.3 | 12.5 |
| CYH-l (25) | 0.99 | 0.3 | 0.9 | 93.1 | 10.6 | 11.6 | 96.5 | 9.6 | 12.6 | 94.3 | 9.6 | 13.6 |
| PER (50) | 0.99 | 0.4 | 1.1 | 95.7 | 14.5 | 15.1 | 93.4 | 16.5 | 17.8 | 90.9 | 10.8 | 15.2 |
| CYF (40) | 0.99 | 0.7 | 2.1 | 90.8 | 8.6 | 14.9 | 87.6 | 9.6 | 12.3 | 92.0 | 9.2 | 9.4 |
| CYP (100) | 0.99 | 0.6 | 1.8 | 88.7 | 10.8 | 13.7 | 90.6 | 8.1 | 10.3 | 95.3 | 12.1 | 14.5 |
| DEL (30) | 0.99 | 0.7 | 2.1 | 95.5 | 8.9 | 15.2 | 92.2 | 9.5 | 12.7 | 90.4 | 8.1 | 11.7 |
| FEV (40) | 0.99 | 0.7 | 2.1 | 99.6 | 12.1 | 10.5 | 101.4 | 11.9 | 14.7 | 97.4 | 12.5 | 14.2 |
| CYH-g | 0.99 | 0.3 | 0.9 | 86.5 | 8.5 | 9.6 | 88.0 | 14.5 | 15.1 | 90.2 | 9.0 | 13.7 |
| CYH-l | 0.99 | 0.3 | 0.9 | 84.2 | 9.0 | 10.2 | 90.2 | 11.3 | 12.0 | 85.6 | 10.6 | 14.6 |
| PER | 0.99 | 0.4 | 1.2 | 88.9 | 9.7 | 12.4 | 93.6 | 12.8 | 12.7 | 92.3 | 11.2 | 12.5 |
| CYF | 0.99 | 0.7 | 2.2 | 90.3 | 13.5 | 13.2 | 90.9 | 9.6 | 11.8 | 94.5 | 8.1 | 9.0 |
| CYP | 0.99 | 0.7 | 2.2 | 88.4 | 12.9 | 14.0 | 87.3 | 8.2 | 10.9 | 89.1 | 10.5 | 11.0 |
| DEL | 0.99 | 0.9 | 2.7 | 85.4 | 11.5 | 11.9 | 93.7 | 13.5 | 15.4 | 90.2 | 15.5 | 15.6 |
| FEV | 0.99 | 1.0 | 3.0 | 88.9 | 13.6 | 15.8 | 91.6 | 14.7 | 16.6 | 92.0 | 12.0 | 13.9 |
Notes: a Values between brackets are the Maximum Limit Residue (μg·L−1) established at NRCP 2013; b Coefficient of regression obtained from matrix-matched calibration curves; c Limit of determination obtained from matrix-matched calibration curves; d Limit of quantification obtained from matrix-matched calibration curves; e Validation level (VL) adopted at 25 μg·L−1; f Recovery expressed as the average of all samples from intra and inter-day experiments; g Intra-day precision expressed as coef-ficient of variation; h Inter-day precision expressed as coefficient of variation.
Figure 4Comparison between chromatographic profiles for GC-ECD analyses (a) in spiked sample (solid line), blank milk (dotted line) and GC-MS/MS for spiked sample (b) and blank milk (c).
Mass spectrometry settings for GC-MS/MS analysis of pyrethroids in MRM mode.
| Analytes | Quantifier a | Qualifier a | ||||
|---|---|---|---|---|---|---|
| Precursorion (m/z) | Production (m/z) | CE (eV) b | Precursorion (m/z) | Production (m/z) | CE (eV) | |
| CYH-g | 181.1 | 127.1 | 30 | 181.1 | 152.1 | 35 |
| CYH-l | 180.0 | 127.1 | 30 | 181.1 | 152.1 | 35 |
| PER | 183.3 | 165.1 | 10 | 183.3 | 168.1 | 15 |
| CYF | 181.1 | 152.1 | 5 | 181.1 | 127.1 | 5 |
| CYP | 163.0 | 127.1 | 5 | 163.0 | 91.1 | 5 |
| DEL | 166.9 | 125.0 | 5 | 124.9 | 89.0 | 5 |
| FEV | 252.8 | 173.9 | 5 | 252.8 | 172.0 | 5 |
Note: a Transitions used for quantification and complementar (qualifier) identification; bCollision energy.